APOTEA — Apotea Sverige AB Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro Cap

Annual income statement for Apotea Sverige AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PRESS	PRESS
Standards:	IFRS	IFRS	—	—
Status:	Final	Final	Final	Final
Revenue
Total Revenue	4,580	4,883	5,450	6,541
Cost of Revenue
Gross Profit	594	559	705	912
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	4,445	4,834	5,337	6,275
Operating Profit	134	48.4	113	266
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	131	31	109	265
Provision for Income Taxes
Net Income After Taxes	105	18.3	82.3	212
Minority Interest
Net Income Before Extraordinary Items
Net Income	105	19.9	87	215
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	105	19.9	87	215
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	57.1	9.76	42.7	2.28